ArticleNeurology international2023

Fremanezumab and Non-High-Dose Galcanezumab for Comorbid Cluster Headache in Patients with Migraine: Three Cases.

Kenta Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.